CY1109553T1 - Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv - Google Patents
Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hivInfo
- Publication number
- CY1109553T1 CY1109553T1 CY20091101257T CY091101257T CY1109553T1 CY 1109553 T1 CY1109553 T1 CY 1109553T1 CY 20091101257 T CY20091101257 T CY 20091101257T CY 091101257 T CY091101257 T CY 091101257T CY 1109553 T1 CY1109553 T1 CY 1109553T1
- Authority
- CY
- Cyprus
- Prior art keywords
- aryl
- group
- different
- alkyl
- substituents
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010354 integration Effects 0.000 title 1
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 150000002391 heterocyclic compounds Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- -1 -N(Q)-(CH2)m- Chemical group 0.000 abstract 1
- 239000004593 Epoxy Substances 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704289A FR2761687B1 (fr) | 1997-04-08 | 1997-04-08 | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
| EP98920581A EP0975597B1 (fr) | 1997-04-08 | 1998-04-07 | Derives de quinoleines en tant qu'inhibiteurs de la vih integrase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109553T1 true CY1109553T1 (el) | 2014-08-13 |
Family
ID=9505648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101257T CY1109553T1 (el) | 1997-04-08 | 2009-12-01 | Παραγωγα κινολεϊνων ως αναστολεις της ιντεγρασης του hiv |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6670377B1 (enExample) |
| EP (1) | EP0975597B1 (enExample) |
| JP (1) | JP4697679B2 (enExample) |
| AT (1) | ATE441634T1 (enExample) |
| CA (1) | CA2286385C (enExample) |
| CY (1) | CY1109553T1 (enExample) |
| DE (1) | DE69841119D1 (enExample) |
| DK (1) | DK0975597T3 (enExample) |
| ES (1) | ES2332434T3 (enExample) |
| FR (1) | FR2761687B1 (enExample) |
| PT (1) | PT975597E (enExample) |
| WO (1) | WO1998045269A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2321348A1 (en) | 2000-09-27 | 2002-03-27 | Blaise Magloire N'zemba | Aromatic derivatives with hiv integrase inhibitory properties |
| FR2819507B1 (fr) * | 2001-01-17 | 2007-09-28 | Inst Rech Developpement Ird | Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus |
| CN1659143A (zh) | 2001-03-01 | 2005-08-24 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的含氮杂芳基化合物 |
| FR2830863B1 (fr) * | 2001-10-12 | 2004-01-30 | Bioalliance Pharma | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
| FR2839646B1 (fr) * | 2002-05-17 | 2008-04-11 | Bioalliance Pharma | Utilisation de derives de quinoleine a effet anti-integrase et ses applications |
| ATE404537T1 (de) | 2002-08-13 | 2008-08-15 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung |
| US7176220B2 (en) * | 2002-11-20 | 2007-02-13 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as pharmaceutical agent |
| RU2275361C3 (ru) * | 2002-11-20 | 2021-10-01 | Джапан Тобакко Инк. | Соединение 4-оксохинолина и его применение в качестве ингибитора вич интегразы |
| MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
| KR100866296B1 (ko) * | 2004-05-20 | 2008-11-11 | 니뽄 다바코 산교 가부시키가이샤 | ４―옥소퀴놀린 화합물의 안정한 결정체 |
| US7531554B2 (en) | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
| JP2008542352A (ja) * | 2005-06-01 | 2008-11-27 | ビオアリアンス ファルマ | キノリン化合物及び他のｈｉｖ感染治療薬を含む相乗作用のコンビネーション |
| JP4669040B2 (ja) | 2006-03-06 | 2011-04-13 | 日本たばこ産業株式会社 | ４−オキソキノリン化合物の製造方法 |
| ES2569660T3 (es) | 2007-06-08 | 2016-05-12 | Mannkind Corporation | Inhibidores de la IRE-1alfa |
| KR20100108337A (ko) * | 2007-11-15 | 2010-10-06 | 베링거 인겔하임 인터내셔날 게엠베하 | 사람 면역결핍 바이러스 복제의 억제제 |
| SI2220076T1 (sl) * | 2007-11-15 | 2012-05-31 | Gilead Sciences Inc | Inhibitorji replikacije virusa humane imunske pomankljivosti |
| JP5269087B2 (ja) * | 2007-11-16 | 2013-08-21 | ギリアード サイエンシス インコーポレーテッド | ヒト免疫不全ウイルス複製のインヒビター |
| US8354429B2 (en) * | 2007-11-16 | 2013-01-15 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
| EP2147912A1 (en) | 2008-07-23 | 2010-01-27 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
| EP2149557A1 (en) | 2008-07-23 | 2010-02-03 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
| EP2147913A1 (en) * | 2008-07-23 | 2010-01-27 | BioAlliance Pharma | Styrylquinolines, their process of preparation and their therapeutic uses |
| EP2588455B1 (en) * | 2010-07-02 | 2018-04-04 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| CA2860015C (en) | 2011-12-22 | 2020-07-07 | Universite Laval | Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1) |
| JP6426694B2 (ja) | 2013-03-15 | 2018-11-21 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
| JP7337174B2 (ja) | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59152891A (ja) * | 1983-02-18 | 1984-08-31 | Yamada Kagaku Kogyo Kk | 発色性記録材料 |
| ES8801209A1 (es) * | 1985-06-18 | 1988-01-01 | Merck Frosst Canada Inc | Un procedimiento para la preparacion de quinolinas 2-sustituidas. |
| EP0219307A3 (en) * | 1985-10-16 | 1987-10-14 | Merck Frosst Canada Inc. | 2-substituted quinolines |
| JPS61189988A (ja) * | 1986-08-11 | 1986-08-23 | Yamada Kagaku Kogyo Kk | 発色性記録材料 |
| JPH01199979A (ja) | 1987-04-07 | 1989-08-11 | Kanebo Ltd | 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤 |
| EP0318093A3 (en) * | 1987-11-25 | 1990-12-05 | Merck Frosst Canada Inc. | Diarylquinoline diacids and their use as medicaments |
| US5438141A (en) * | 1993-05-21 | 1995-08-01 | Merck Frosst Canada, Inc. | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
| EP0643045B1 (de) * | 1993-09-10 | 2000-03-08 | Novartis AG | Chinolin-Verbindungen als Leukotriene Antagonisten |
| GB9414590D0 (en) * | 1994-07-20 | 1994-09-07 | Leo Pharm Prod Ltd | Chemical compounds |
| ES2103180B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Fenilacetamidas con accion antagonista de los leucotrienos. |
| EP0725063A1 (de) * | 1995-02-01 | 1996-08-07 | Ciba-Geigy Ag | Chinolin-Derivate |
| AU4172197A (en) * | 1996-09-10 | 1998-04-02 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
-
1997
- 1997-04-08 FR FR9704289A patent/FR2761687B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-07 DK DK98920581T patent/DK0975597T3/da active
- 1998-04-07 AT AT98920581T patent/ATE441634T1/de active
- 1998-04-07 PT PT98920581T patent/PT975597E/pt unknown
- 1998-04-07 WO PCT/FR1998/000701 patent/WO1998045269A1/fr not_active Ceased
- 1998-04-07 US US09/402,858 patent/US6670377B1/en not_active Expired - Fee Related
- 1998-04-07 ES ES98920581T patent/ES2332434T3/es not_active Expired - Lifetime
- 1998-04-07 CA CA2286385A patent/CA2286385C/fr not_active Expired - Fee Related
- 1998-04-07 DE DE69841119T patent/DE69841119D1/de not_active Expired - Lifetime
- 1998-04-07 JP JP54245998A patent/JP4697679B2/ja not_active Expired - Fee Related
- 1998-04-07 EP EP98920581A patent/EP0975597B1/fr not_active Expired - Lifetime
-
2009
- 2009-12-01 CY CY20091101257T patent/CY1109553T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE441634T1 (de) | 2009-09-15 |
| FR2761687A1 (fr) | 1998-10-09 |
| DE69841119D1 (de) | 2009-10-15 |
| EP0975597B1 (fr) | 2009-09-02 |
| CA2286385C (fr) | 2011-02-01 |
| ES2332434T3 (es) | 2010-02-04 |
| WO1998045269A1 (fr) | 1998-10-15 |
| JP2001518890A (ja) | 2001-10-16 |
| JP4697679B2 (ja) | 2011-06-08 |
| US6670377B1 (en) | 2003-12-30 |
| PT975597E (pt) | 2010-01-04 |
| FR2761687B1 (fr) | 2000-09-15 |
| DK0975597T3 (da) | 2009-11-02 |
| CA2286385A1 (fr) | 1998-10-15 |
| EP0975597A1 (fr) | 2000-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0975597T3 (da) | Chinolinderivater som inhibitorer af HIV-integrase | |
| WO2000010965A3 (en) | Quaternary ammonium salts and their use as anti-hiv agents | |
| PT87700A (pt) | Process for the preparation of a new pyrazolopyridine compound | |
| MX9504349A (es) | Derivados de aroilpiperidina. | |
| CA2134359A1 (en) | New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) | |
| EA200100970A1 (ru) | Аминопроизводные как ингибиторы протеазы | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| TR200100432T2 (tr) | Hepatit C inhibitörü tri-peptidler | |
| IE831564L (en) | N-substituted imidazoles | |
| NO20023995D0 (no) | 2-okso-1-pyrrolidinderivater, fremgangsmåte for fremstilling og anvendelse av disse | |
| EA200600348A1 (ru) | Новые соединения | |
| WO2003068750A1 (en) | Jnk inhibitor | |
| HUP9800295A2 (hu) | Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik | |
| HRP20010573B1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
| DK0848004T3 (da) | Pyrrolidinderivater med inhiberende aktivitet mod phospholipase A2 | |
| HUP9802315A2 (hu) | Trombin inhibitorok, eljárás előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
| DK0916646T3 (da) | Fremgangsmåde til fremstillingen af en substitueret 2,5-diamino-3-hydroxyhexan | |
| JPS56115784A (en) | Novel pyridinecarboxamide derivative and its preparation | |
| ID24846A (id) | Turunan-turunan bifenilamidina | |
| EA200401482A1 (ru) | Ненуклезидные ингибиторы обратной транскриптазы | |
| DK0785789T3 (da) | Diazepinindoler som phosphodiesterase IV-inhibitorer | |
| DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
| ATE235468T1 (de) | Plättchenaggregationsinhibitoren | |
| WO2001022951A3 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| DK0701551T3 (da) | 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister |